The autonomic nervous system and cardiovascular disease: role of n-3 PUFAs

Vascul Pharmacol. 2015 Aug:71:1-10. doi: 10.1016/j.vph.2015.02.005. Epub 2015 Apr 11.

Abstract

In the last decades, a large body of experimental and clinical evidence has been accumulated showing that cardiovascular diseases are often accompanied by an imbalance in the sympathetic-vagal outflow to the heart, resulting in a chronic adrenergic activation. The arterial baroreceptor system is a key component of mechanisms contributing to the neural regulation of the cardiovascular system. Several methods have been proposed to assess autonomic activity by analyzing heart rate and blood pressure changes either spontaneously occurring or following provocations. The autonomic nervous system has been regarded as one of the putative mechanisms involved into the beneficial effects of exposure to n-3 fatty acids observed in epidemiological studies. The aim of the present review is to provide an update on the clinical evidence proposed so far linking exposure to n-3 fatty acids to autonomic nervous system modulation.

Keywords: Autonomic nervous system; Baroreflex sensitivity; Cardiovascular disease; Heart rate variability; n-3 PUFA.

Publication types

  • Review

MeSH terms

  • Animals
  • Autonomic Nervous System / drug effects*
  • Autonomic Nervous System / physiology*
  • Blood Pressure / drug effects
  • Blood Pressure / physiology
  • Cardiovascular Diseases / metabolism
  • Cardiovascular Diseases / prevention & control*
  • Fatty Acids, Omega-3 / pharmacology
  • Fatty Acids, Omega-3 / physiology*
  • Fatty Acids, Omega-3 / therapeutic use*
  • Heart Rate / drug effects
  • Heart Rate / physiology
  • Humans
  • Neural Pathways / drug effects
  • Neural Pathways / physiology
  • Vagus Nerve / drug effects
  • Vagus Nerve / physiology

Substances

  • Fatty Acids, Omega-3